naltrexone and Head and Neck Neoplasms

naltrexone has been researched along with Head and Neck Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Cata, JP; Corrales, G; Gleber-Netto, FO; Gorur, A; Myers, JN; PatiƱo, M; Pickering, C; Rangel, R; Shi, T; Takahashi, H1
McLaughlin, PJ; Zagon, IS1
Levin, RJ; McLaughlin, PJ; Ohlsson-Wilhelm, BM; Roesener, CD; Verderame, MF; Zagon, IS1

Other Studies

3 other study(ies) available for naltrexone and Head and Neck Neoplasms

ArticleYear
Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor.
    Journal of cellular physiology, 2021, Volume: 236, Issue:11

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Head and Neck Neoplasms; Humans; Male; Mice, Inbred C57BL; Mice, Nude; Naltrexone; Narcotic Antagonists; Neoplasm Invasiveness; Quaternary Ammonium Compounds; Receptors, Opioid, mu; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Tumor Burden; Xenograft Model Antitumor Assays

2021
Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.
    International journal of oncology, 2004, Volume: 24, Issue:6

    Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Adhesion; Cell Division; Colonic Neoplasms; Colony-Forming Units Assay; Enkephalin, Methionine; Head and Neck Neoplasms; Humans; Naloxone; Naltrexone; Narcotic Antagonists; Pancreatic Neoplasms; Receptors, Opioid; Transplantation, Heterologous; Tumor Cells, Cultured

2004
Opioid growth factor regulates the cell cycle of human neoplasias.
    International journal of oncology, 2000, Volume: 17, Issue:5

    Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Colonic Neoplasms; DNA Replication; Enkephalin, Methionine; Head and Neck Neoplasms; Humans; Naltrexone; Narcotic Antagonists; Neoplasm Proteins; Neoplasms; Pancreatic Neoplasms; Receptors, Opioid; Resting Phase, Cell Cycle; Tumor Cells, Cultured; Tumor Stem Cell Assay

2000